Cases 21 - 30 of 71
PAR PHARMACEUTICAL, INC. et al v. CIPLA LIMITED et al
as 3:2022cv02814
Plaintiff:
PAR PHARMACEUTICAL, INC., PAR STERILE PRODUCTS, LLC and ENDO PAR INNOVATION COMPANY, LLC
Defendant:
CIPLA LIMITED and CIPLA USA, INC.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
PAR PHARMACEUTICAL, INC. et al v. CIPLA LIMITED et al
as 2:2022cv02814
Plaintiff:
PAR PHARMACEUTICAL, INC., PAR STERILE PRODUCTS, LLC and ENDO PAR INNOVATION COMPANY, LLC
Counter Claimant:
CIPLA LIMITED
Defendant:
CIPLA USA, INC.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Acerta Pharma B.V. et al v. Cipla Limited et al
as 1:2022cv00162
Plaintiff:
Acerta Pharma B.V., AstraZeneca UK Limited, AstraZeneca Pharmaceuticals LP and others
Defendant:
Cipla Limited and Cipla USA, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
UCB, Inc. et al v. Cipla Limited et al
as 1:2021cv01229
Plaintiff:
UCB, Inc., UCB Biopharma SRL, Hananja EHF and others
Defendant:
Cipla Limited and Cipla USA Inc.
Cause Of Action: 35 U.S.C. § 271
Pfizer Inc. et al v. Cipla, Ltd. et al
as 1:2020cv01393
Plaintiff:
Pfizer Inc., Warner-Lambert Company LLC and PF PRISM IMB B.V.
Defendant:
Cipla, Ltd. and Cipla USA Inc.
Cause Of Action: 35 U.S.C. § 271
ViiV Healthcare Company et al v. Cipla Limited et al
as 1:2020cv00977
Plaintiff:
ViiV Healthcare UK (No. 3) Limited, Shionogi & Co., Ltd. and ViiV Healthcare Company
Defendant:
Cipla Limited and Cipla USA, Inc.
Cause Of Action: 35 U.S.C. § 271
Biogen International GmbH v. Cipla Limited et al
as 1:2019cv02210
Defendant:
Cipla Limited and Cipla USA Inc.
Plaintiff:
Biogen International GmbH
Cause Of Action: 35 U.S.C. § 271
ViiV Healthcare Company et al v. Cipla Limited et al
as 1:2019cv02085
Plaintiff:
ViiV Healthcare UK (No. 3) Limited, Shionogi & Co., Ltd. and ViiV Healthcare Company
Defendant:
Cipla Limited and Cipla USA, Inc.
Cause Of Action: 35 U.S.C. § 271
In re: Palbociclib Patent Litigation
as 1:2019md02912
Not Classified By Court:
Aizant Drug Research Solutions Pvt. Ltd., Hetero USA Inc., Teva Pharmaceuticals USA, Inc. and others
In Re:
In re: Palbociclib Patent Litigation
Cause Of Action: 35 U.S.C. § 271
Boehringer Ingelheim Pharmaceuticals Inc. v Cipla Limited et al
as 1:2019cv01494
Defendant:
Cipla USA, Inc. and Cipla Limited
Plaintiff:
Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharmaceuticals Inc. and Boehringer Ingelheim International GmbH
Cause Of Action: 35 U.S.C. § 271
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
